Five-year results of photodynamic therapy with verteporfin for Japanese patients with neovascular age-related macular degeneration
Takashi Tsuchihashi, Keisuke Mori, Kazuhiro Ueyama, Shin Yoneya Department of Ophthalmology, Saitama Medical University, Iruma, Saitama, Japan Purpose: To describe the treatment outcome of photodynamic therapy (PDT) in Japanese patients with age-related macular degeneration (AMD) followed for 5 year...
Guardado en:
Autores principales: | Tsuchihashi T, Mori K, Ueyama K, Yoneya S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f891854e2cc94cc7b638f11874895025 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prognostic phenotypic and genotypic factors associated with photodynamic therapy response in patients with age-related macular degeneration
por: Tsuchihashi T, et al.
Publicado: (2014) -
Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial
por: Gallemore RP, et al.
Publicado: (2017) -
Drusen and pigment abnormality predict the development of neovascular age-related macular degeneration in Japanese patients.
por: Shoji Notomi, et al.
Publicado: (2021) -
Specific Autoantibodies in Neovascular Age-Related Macular Degeneration: Evaluation of Morphological and Functional Progression over Five Years
por: Michelle Prasuhn, et al.
Publicado: (2021) -
Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration
por: Mamdouh M Kabeel, et al.
Publicado: (2008)